Health and Human Services Logo

  U.S. Department of Health and Human Services | National Institutes of Health

Biologics Regulation and ResearchThe People and Work of Buildings 29 & 29A

Versions Compared

Old Version 25

changes.mady.by.user Katie Watts

Saved on

compared with

New Version Current

changes.mady.by.user Lyons, Michele (NIH/OD) [E]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Yellow Fever

Yellow fever had has been around since at least the 18th century and was known and dreaded throughout the 19th century, especially in port towns with the arrival of new ships. It was endemic in Cuba, and so after the Spanish-American War, a Yellow Fever Commission was established in the United States to investigate the disease. Walter Reed was the head of the commission, which established that mosquitoes transmitted the disease. The focus shifted to prevention via mosquito control.

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-6

At the same time, a “French strain” was discovered in Dakar, Senegal. Andrew Watson Sellards from Harvard and his team discovered the virus survived freezing, allowing transport of infected liver tissue. There were some crude vaccines using formalin and phenol-preserved liver tissue but with uncertain results. Max Theiler knew they needed a better host, so he then inoculated mice intracerebrally and found that the virus grew well. He created the first attenuated strain of yellow fever but with increased neurotropism.

The Rockefeller Foundation was involved in research in West Africa. Tragically, many of the lead researchers died of yellow fever from the 1925 expedition, but they were able to infect rhesus monkeys and therefore could remove the virus to the lab and study it. They discovered that serum from immune humans protected monkeys against infection, immune serum from South America protected against the African virus, and the killed virus would not confer immunity.

Dive
classgrid-col-6

black and white photograph of Walter Reed in 1874 in Murfreesboro, North Carolina. He is a young looking man with short hair, wearing a black bowtie and white collared shirt.

Center
Span
classcaption

1874 Image of Walter Reed.

Span
classcredit

National Library of Medicine

Back in New York, the Rockefeller Institute continued their highly dangerous work on yellow fever. The Rockefeller vaccine was used in the United States and England. At the same time, the Pasteur Institute in Tunis developed a one-dose vaccine (usually combined with smallpox), and it was used in France and their African colonies. The French vaccine was given by scarification (scratching into the skin). It risked febrile and central nervous system reactions but could be done en masson crowds of people at one time.

In 1932, new technique of cultivating the virus in embryonated eggs and freeze drying them came into use. The 17D virus strain from a chance mutation at the Rockefeller Institute was attenuated enough that it didn’t need protective immune serum. Trials continued in South America, but there were problems with encephalitis and jaundice.

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-12

Old map showing areas of yellow fever from 1933-1943, endemic areas as shown by protection tests, and distribution of vectors of yellow fever

Span
classcaption

1943 Map of Yellow Fever from the U.S. Army.

Span
classcredit

National Library of Medicine

World War II created a huge demand for the yellow fever vaccine. The United States used the Rockefeller Institute vaccine for almost 7 million doses. Later some 26,000 cases of jaundice were recorded and mortality rates of 3 per 1000 (but it was later shown to be Hep. hepatitis B). An investigation ensued. The serum seemed to be the culprit. Serum was donated by those affiliated with the Johns Hopkins' School of Medicine. When the serum was ultimately tested, it was revealed that several of the donors had a history of jaundice.

...
Return to top